BRPI0512054A - compostos contendo boro e métodos de utilização - Google Patents

compostos contendo boro e métodos de utilização

Info

Publication number
BRPI0512054A
BRPI0512054A BRPI0512054-3A BRPI0512054A BRPI0512054A BR PI0512054 A BRPI0512054 A BR PI0512054A BR PI0512054 A BRPI0512054 A BR PI0512054A BR PI0512054 A BRPI0512054 A BR PI0512054A
Authority
BR
Brazil
Prior art keywords
methods
containing compounds
boron containing
antibiotics
acne
Prior art date
Application number
BRPI0512054-3A
Other languages
English (en)
Inventor
David Perry
Kirk R Maples
Carolyn Bellinger-Kawahara
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0512054A publication Critical patent/BRPI0512054A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSTOS CONTENDO BORO E MéTODOS DE UTILIZAçãO São apresentados métodos de tratamento e/ou prevenção de infecções superficiais tais como acne, em um animal, tal como um ser humano, usando antibióticos que incorporam complexos de ácido borínico, especialmente derivados de ácido picolínico, junto com composições destes antibióticos.
BRPI0512054-3A 2004-06-14 2005-06-14 compostos contendo boro e métodos de utilização BRPI0512054A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57942104P 2004-06-14 2004-06-14
PCT/US2005/021165 WO2005123094A2 (en) 2004-06-14 2005-06-14 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones

Publications (1)

Publication Number Publication Date
BRPI0512054A true BRPI0512054A (pt) 2008-02-06

Family

ID=35276660

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512054-3A BRPI0512054A (pt) 2004-06-14 2005-06-14 compostos contendo boro e métodos de utilização

Country Status (18)

Country Link
US (1) US7652000B2 (pt)
EP (1) EP1765358B1 (pt)
JP (1) JP2008502696A (pt)
KR (1) KR20070043776A (pt)
CN (1) CN1972695A (pt)
AR (1) AR049915A1 (pt)
AT (1) ATE499105T1 (pt)
AU (1) AU2005254095B2 (pt)
BR (1) BRPI0512054A (pt)
CA (1) CA2570477A1 (pt)
DE (1) DE602005026524D1 (pt)
IL (1) IL179616A0 (pt)
MX (1) MXPA06014416A (pt)
NZ (1) NZ551726A (pt)
RU (1) RU2007101309A (pt)
TW (1) TW200612966A (pt)
WO (1) WO2005123094A2 (pt)
ZA (1) ZA200610353B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5038912B2 (ja) 2005-02-16 2012-10-03 アナコール ファーマシューティカルズ，インコーポレイテッド ホウ素含有小分子
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
RU2007139316A (ru) * 2005-03-24 2009-04-27 Анакор Фармасьютикалз, Инк. (Us) Местные композиции антибиотиков бориновой кислоты и способы их использования
US20070179296A1 (en) * 2005-12-28 2007-08-02 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
NZ570257A (en) 2006-02-16 2011-11-25 Anacor Pharmaceuticals Inc Boron-containing small molecules as anti-inflammatory agents
RU2008152367A (ru) * 2006-06-12 2010-07-20 Анакор Фармасьютикалз, Инк. (Us) Соединения для лечения периодонтального заболевания
BRPI0908565A2 (pt) 2008-03-06 2017-05-23 Anacor Pharmaceuticals Inc composto, formulação farmacêutica, métodos para reduzir a liberação de uma citocina ou de uma quimiocina, para tratar uma condição em um animal e para inibir uma fosfodiesterase
JP5606913B2 (ja) * 2008-08-11 2014-10-15 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
EP2348863A4 (en) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
US8461336B2 (en) 2008-09-04 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US9493489B2 (en) * 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
TW201109022A (en) 2009-06-03 2011-03-16 Colgate Palmolive Co Borinic compositions
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
WO2011049971A1 (en) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en) 2009-11-11 2011-09-01 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
SG10201507032YA (en) 2010-09-07 2015-10-29 Anacor Pharmaceuticals Inc Benzoxaborole derivatives for treating bacterial infections
DK2950644T3 (en) 2013-01-30 2017-09-04 Agrofresh Inc USE OF BENZOXABOROLS AS VOLATIVE ANTIMICROBIAL AGENTS IN MEAT, PLANTS OR PARTS
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
IES86830B2 (en) * 2015-06-24 2017-10-04 Oriel Seasalt Company Ltd A super-concentrated seawater mineral extract and uses thereof
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790627A (fr) * 1971-10-27 1973-04-27 Lilly Co Eli L'antibiotique a477 et son procede de preparation
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US6123925A (en) * 1998-07-27 2000-09-26 Healthshield Technologies L.L.C. Antibiotic toothpaste
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
JP2003514023A (ja) 1999-11-19 2003-04-15 トツプジーン・インコーポレイテツド 抗炎症剤としてのホウ素化合物および複合体
EP1980564A1 (en) * 2002-12-18 2008-10-15 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
RU2007101309A (ru) 2008-07-20
IL179616A0 (en) 2007-05-15
AU2005254095A1 (en) 2005-12-29
US20060009422A1 (en) 2006-01-12
TW200612966A (en) 2006-05-01
ATE499105T1 (de) 2011-03-15
US7652000B2 (en) 2010-01-26
JP2008502696A (ja) 2008-01-31
WO2005123094A3 (en) 2006-02-23
AR049915A1 (es) 2006-09-13
CN1972695A (zh) 2007-05-30
DE602005026524D1 (de) 2011-04-07
WO2005123094A2 (en) 2005-12-29
MXPA06014416A (es) 2007-03-08
CA2570477A1 (en) 2005-12-29
ZA200610353B (en) 2010-07-28
EP1765358B1 (en) 2011-02-23
NZ551726A (en) 2010-09-30
KR20070043776A (ko) 2007-04-25
AU2005254095B2 (en) 2010-06-03
EP1765358A2 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
TW200612966A (en) Boron-containing compounds and methods of use
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
BR0308854A (pt) Benzazolas substituìdas e seus usos como inibidoras de quinase raf
ECSP088425A (es) INHIBIDORES DE LA ACTIVIDAD Akt
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
BRPI0317696B8 (pt) composição para branqueamento
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
PT1411908E (pt) Tratamento de infeccoes da unha com no
MXPA05010819A (es) Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
CY1110498T1 (el) Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα
ATE484508T1 (de) Furylverbindungen
WO2007127006A3 (en) Sterilization methods and systems
BRPI0515012A (pt) substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso
BRPI0414908A (pt) compostos de benzazóis substituìdos, composições e métodos de inibição da atividade raf quinase em um humano ou animal
BRPI0411016A (pt) composições antisépticas, processos e sistemas
NO20032759L (no) 2-fenylbenzimidazoler og imidazo-[4,5]-pyridiner som Cds1/Chk2-inhibitorerog adjuvanter for kjemoterapi eller strålingsterapi ved behandlingav cancer
CL2008001533A1 (es) Formulacion que comprende triazinonas y compuestos o complejos ferricos, utiles para preparar medicamentos para uso veterinario contra la coccidiosis y deficiencias de hierro.
MY158428A (en) Topical composition for the treatment of actinic keratosis
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
BR112022001054A2 (pt) Inibidores enzimáticos
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
BR112022000936A2 (pt) Inibidores de enzimas
BR112022001390A2 (pt) Inibidores de enzima
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
BRPI0506888A (pt) composições de suplemento lìquido compreendendo um ou mais medicamentos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.